# Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents

> **NCT00011479** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 24 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Abacavir sulfate

## Key facts

- **NCT ID:** NCT00011479
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2002-08
- **Target enrollment:** 24 (—)
- **Last updated:** 2021-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00011479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00011479, "Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00011479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*